Skip to main content

Hematology: Chronic Lymphocytic Leukemia (CLL): Baseline Flow Cytometry

CBE ID
0379
1.4 Project
Cancer
Endorsed
Endorsement Status
Endorsement Removed
1.1 New or Maintenance
Maintenance
E&M Cycle
Fall 2017
Is Under Review
No
1.3 Measure Description

Percentage of patients aged 18 years and older, seen within a 12 month reporting period, with a diagnosis of chronic lymphocytic leukemia (CLL) made at any time during or prior to the reporting period who had baseline flow cytometry studies performed and documented in the chart

    • 1.14 Numerator

      Patients who had baseline flow cytometry studies performed and documented in the chart

    • 1.15 Denominator

      All patients aged 18 years and older, seen within a 12 month reporting period, with a diagnosis of chronic lymphocytic leukemia (CLL) made at any time during or prior to the reporting period

    • Exclusions

      For Claims/Registry:

      Documentation of medical reason(s) for not performing baseline flow cytometry studies

      Documentation of patient reason(s) for not performing baseline flow cytometry studies (eg, receiving palliative care or not receiving treatment as defined above)

      Documentation of system reason(s) for not performing baseline flow cytometry studies (eg, patient previously treated by another physician at the time baseline flow cytometry studies were performed)

    • Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Cancer Fall Cycle 2017
      Initial Endorsement
      Last Updated
      Removal Date